Dr. Dougan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-724-6007
Education & Training
Massachusetts General HospitalFellowship, Gastroenterology, 2013 - 2015- Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
Harvard Medical SchoolClass of 2011
Certifications & Licensure
MA State Medical License 2011 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis Start of enrollment: 2020 Aug 31
Publications & Presentations
PubMed
- 2 citationsNovel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.Yinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, Malek Shatila, David Faleck
Gastrointestinal Endoscopy. 2024-08-01 - 3 citationsTofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis.Mike Wang, Kerry L Reynolds, Kamaneh Montazeri, Esperance A Schaefer, Ryan J Sullivan
Clinical Gastroenterology and Hepatology. 2024-07-01 - 8 citationsAn esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission.Jiarui Ding, John J Garber, Amiko Uchida, Ariel Lefkovith, Grace T Carter
Nature Communications. 2024-04-18
Journal Articles
- Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHsMichael Dougan, MD, Clinical Cancer Research
Press Mentions
New Weapons Against Cancer: Millions of Bacteria Programmed to KillJuly 5th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
